Core A: Administrative Core
Core A: Administrative Core
批准号:
10472763
负责人:
DAVID ALAN BENNETT
金额:
$26.61万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-06-30
关键词:
Academic Medical CentersAchievementAddressAdministratorAdvisory CommitteesAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease therapeuticBiological MarkersBlack PopulationsBrainClinical ResearchClinical TrialsCohort StudiesCollaborationsCommunicationCommunitiesDataDementiaDevelopmentDiagnosisDiseaseEnsureEtiologyExerciseFacultyFamily StudyFundingFunding MechanismsFutureGenerationsGenetic DiseasesGoalsInfrastructureInstitutionInternationalInvestmentsKnowledgeLatinoLeadershipMonitorNCI Scholars ProgramNational Institute on AgingPathogenesisPharmacologyPhenotypePopulation StudyPrecision HealthReportingResearchResearch InstituteResearch PersonnelResource SharingResourcesReview Committeebasecohortcollaborative environmentdata hubdesigneducation researchhealth equityinnovationmeetingsneuroimagingnew therapeutic targetprecision medicinesummer internshipuser-friendly
中文摘要
摘要-行政核心
拟议的拉什ADRC的总体目标是创造一个跨学科的环境,支持
阿尔茨海默病病因、发病机制、诊断、治疗和预防创新研究
和相关痴呆(AD/ADRD)行政核心将行使全面的科学领导权
设定Rush ADRC的总体方向,确保Rush ADRC的最佳利用
促进《发展与复兴》国家适应行动方案里程碑的执行,并作为其他
国家和地方一级的老龄化和AD/ADRD活动。它将1)确保每个其他核心,
学员通过建立有效的沟通和互动来实现他们的目标和最大的潜力
通过执行委员会; 2)指导ADRC使用机构资源; 3)支持用户-
友好的机制,以促进使用拉什ADRC资源的更广泛的老龄化和AD/ADRD研究
社区,地方,国家和国际,通过资源分配委员会; 4)确定和
支持高质量的开发项目和拉什ADRC研究学者; 5)确保积极和
建设性地参与与其他组织的合作努力,促进研究和了解
AD/ADRD,包括RUMC、NIA ADRC和其他工作; 6)监测成就并修改目标,
通过外部咨询委员会确定未来方向。
这些目标通过精心设计和整合行政核心与其他目标得到支持。
七个核心和研究教育组成部分,包括拉什ADRC。Rush ADRC地址
国家适应行动方案的许多里程碑,包括:1)通过3项社区队列研究和2项
由Rush ADRC研究者进行的R 01资助的附属队列研究,所有研究均与
ROS核心。它们包括多层次、多区域的组学数据,用于精准医疗和健康公平,
队列仅包括黑人和一个拉丁裔,另外两项研究主要是非拉丁裔
白色,2)通过脑深部表型分析的疾病机制,3)转化临床研究-药理学
通过产生用于临床试验的潜在受试者,4)通过神经成像的生物标志物和诊断,
生物流体生物标志物,以及5)通过我们的资源共享中心启用基础设施,
https://www.radc.rush.edu/.
英文摘要
ABSTRACT – ADMINISTRATIVE CORE
The overall goal of the proposed Rush ADRC is to create an inter-disciplinary environment that supports
innovative research on etiology, pathogenesis, diagnosis, treatment, and prevention of Alzheimer’s dementia
and related dementias (AD/ADRD). The Administrative (Admin) Core will exercise overall scientific leadership
of the Rush ADRC to set the overall direction of the Rush ADRC, ensure optimal utilization of Rush ADRC
resources, promote the implementation of the ADRD NAPA milestones, and serve as a resource for other
aging and AD/ADRD activities at the national and local level. It will 1) ensure that each of the other Cores, and
trainees reach their goals and greatest potential by establishing effective communication and interaction
through the Executive Committee; 2) guide the use of institutional resources for the ADRC; 3) support a user-
friendly mechanism to facilitate the use of Rush ADRC resources by the wider aging and AD/ADRD research
community, locally, nationally, and internationally, through the Resource Distribution Committee; 4) identify and
support high quality development projects and Rush ADRC Research Scholars; 5) ensure active and
constructive participation in collaborative efforts with other organizations, advance research and knowledge of
AD/ADRD, including RUMC, NIA ADRCs and other efforts; 6) monitor achievements and modify goals and
future directions through the External Advisory Committee.
These aims are supported through the careful design and integration of the Administrative Core with the other
seven Cores and Research Education Component that comprise the Rush ADRC. The Rush ADRC addresses
many of the NAPA Milestones including: 1) population studies via 3 community-based cohort studies and two
affiliated cohort studies funded as R01s conducted by Rush ADRC investigators that are all harmonized to the
ROS Core. They include multi-level, multi-region omic data for precision medicine and health equity as two
cohorts are exclusively of Blacks and one of Latino and the two other studies are predominantly non-Latino
white, 2) disease mechanisms via deep brain phenotyping, 3) translational clinical research – pharmacological
through the generation of potential subjects for clinical trials, 4) biomarkers & diagnosis via neuroimaging and
biofluid biomarkers, and 5) enabling infrastructure via our Resource Sharing Hub at
https://www.radc.rush.edu/.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
-
批准号:10590405
-
项目类别:
-
资助金额:$367.18万
-
财政年份:2023
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
-
批准号:10655203
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2023
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core H: Religious Orders Study Core
-
批准号:10264500
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core A: Administrative Core
-
批准号:10264494
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core H: Religious Orders Study Core
-
批准号:10472772
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core H: Religious Orders Study Core
-
批准号:10669651
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Core A: Administrative Core
-
批准号:10669634
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Rush Alzheimer's Disease Research Center
-
批准号:10264493
-
项目类别:
-
资助金额:$312.77万
-
财政年份:2021
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
-
批准号:10172823
-
项目类别:
-
资助金额:$73.29万
-
财政年份:2019
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
-
批准号:10404653
-
项目类别:
-
资助金额:$71.38万
-
财政年份:2019
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
-
批准号:10655334
-
项目类别:
-
资助金额:$69.25万
-
财政年份:2019
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:9789157
-
项目类别:
-
资助金额:$164.86万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10251981
-
项目类别:
-
资助金额:$224.23万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10475098
-
项目类别:
-
资助金额:$272.88万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10375865
-
项目类别:
-
资助金额:$41.66万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Integration of immune cell subtypes across diseases & tissue
-
批准号:10518099
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
A shared foundation for single genetic investigations of immune responses
-
批准号:10518096
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10075554
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
-
批准号:10013100
-
项目类别:
-
资助金额:$305.0万
-
财政年份:2018
-
负责人:DAVID ALAN BENNETT
-
依托单位:
Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimer?sDisease
-
批准号:9816512
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2016
-
负责人:DAVID ALAN BENNETT
-
依托单位:
海外基金